These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20187249)

  • 1. Gene therapy for Parkinson's disease.
    Bjorklund T; Kordower JH
    Mov Disord; 2010; 25 Suppl 1():S161-73. PubMed ID: 20187249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are growth factors the answer?
    Ramaswamy S; Kordower JH
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S176-80. PubMed ID: 20082985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for Parkinson's disease.
    Lawlor PA; During MJ
    Expert Rev Mol Med; 2004 Mar; 6(5):1-18. PubMed ID: 15000692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy in Parkinson's disease.
    Eberhardt O; Schulz JB
    Cell Tissue Res; 2004 Oct; 318(1):243-60. PubMed ID: 15322915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upcoming treatments in Parkinson's disease, including gene therapy.
    Rodnitzky RL
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S37-40. PubMed ID: 22166449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLX-P101, an adeno-associated virus gene therapy encoding glutamic acid decarboxylase, for the potential treatment of Parkinson's disease.
    Diaz-Nido J
    Curr Opin Investig Drugs; 2010 Jul; 11(7):813-22. PubMed ID: 20571977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of growth factors for the treatment of Parkinson's disease.
    Yasuda T; Mochizuki H
    Expert Rev Neurother; 2010 Jun; 10(6):915-24. PubMed ID: 20518608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical development of gene therapy for Parkinson's disease.
    Porras G; Bezard E
    Exp Neurol; 2008 Jan; 209(1):72-81. PubMed ID: 17904121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Future of gene therapy for Parkinson's disease].
    Mochizuki H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):948-50. PubMed ID: 15651340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for Parkinson's disease: an approach to the prevention or palliation of levodopa-associated motor complications.
    Mouradian MM; Chase TN
    Exp Neurol; 1997 Mar; 144(1):51-7. PubMed ID: 9126152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GDNF therapy for Parkinson's disease.
    Hong M; Mukhida K; Mendez I
    Expert Rev Neurother; 2008 Jul; 8(7):1125-39. PubMed ID: 18590482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy approaches to Parkinson's disease: preclinical to clinical trials, or what steps to take to get there from here?
    Redmond DE
    Exp Neurol; 1997 Mar; 144(1):160-7. PubMed ID: 9126166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene therapy for Parkinson's disease].
    Muramatsu S
    Brain Nerve; 2007 Apr; 59(4):425-30. PubMed ID: 17447529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of ex vivo gene therapy in the treatment of Parkinson's disease.
    Raymon HK; Thode S; Gage FH
    Exp Neurol; 1997 Mar; 144(1):82-91. PubMed ID: 9126156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for gene therapy in Parkinson's disease.
    Freese A; Stern M; Kaplitt MG; O'Connor WM; Abbey MV; O'Connor MJ; During MJ
    Mov Disord; 1996 Sep; 11(5):469-88. PubMed ID: 8866488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA knockdown as a potential therapeutic strategy in Parkinson's disease.
    Manfredsson FP; Lewin AS; Mandel RJ
    Gene Ther; 2006 Mar; 13(6):517-24. PubMed ID: 16267570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for dopamine replacement in Parkinson's disease.
    Björklund A; Björklund T; Kirik D
    Sci Transl Med; 2009 Oct; 1(2):2ps2. PubMed ID: 20368161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for Parkinson's disease: from non-human primates to humans.
    Fiandaca MS; Bankiewicz KS
    Curr Opin Mol Ther; 2010 Oct; 12(5):519-29. PubMed ID: 20886383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.